| Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial SR Rapp, MA Espeland, SA Shumaker, VW Henderson, RL Brunner, ... Jama 289 (20), 2663-2672, 2003 | 1172 | 2003 |
| Estrogen deficiency and risk of Alzheimer's disease in women A Paganini-Hill, VW Henderson American journal of epidemiology 140 (3), 256-261, 1994 | 1169 | 1994 |
| Postmenopausal hormone therapy: an Endocrine Society scientific statement RJ Santen, DC Allred, SP Ardoin, DF Archer, N Boyd, GD Braunstein, ... The Journal of Clinical Endocrinology & Metabolism 95 (7_supplement_1), s1-s66, 2010 | 896 | 2010 |
| Estrogen replacement therapy in older women: comparisons between Alzheimer's disease cases and nondemented control subjects VW Henderson, A Paganini-Hill, CK Emanuel, ME Dunn, JG Buckwalter Archives of Neurology 51 (9), 896-900, 1994 | 813 | 1994 |
| Sex modifies the APOE‐related risk of developing Alzheimer disease A Altmann, L Tian, VW Henderson, MD Greicius, ... Annals of neurology 75 (4), 563-573, 2014 | 804 | 2014 |
| Vascular effects of early versus late postmenopausal treatment with estradiol HN Hodis, WJ Mack, VW Henderson, D Shoupe, MJ Budoff, ... New England Journal of Medicine 374 (13), 1221-1231, 2016 | 751 | 2016 |
| Estrogen for Alzheimer’s disease in women: randomized, double-blind, placebo-controlled trial VW Henderson, A Paganini-Hill, BL Miller, RJ Elble, PF Reyes, D Shoupe, ... Neurology 54 (2), 295-295, 2000 | 728 | 2000 |
| Estrogen replacement therapy and risk of Alzheimer disease A Paganini-Hill, VW Henderson Archives of internal medicine 156 (19), 2213-2217, 1996 | 726 | 1996 |
| Boston Naming Test: shortened versions for use in Alzheimer's disease WJ Mack, DM Freed, BW Williams, VW Henderson Journal of gerontology 47 (3), P154-P158, 1992 | 651 | 1992 |
| White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study G Bartzokis, JL Cummings, D Sultzer, VW Henderson, KH Nuechterlein, ... Archives of neurology 60 (3), 393-398, 2003 | 558 | 2003 |
| Age of menopause and impact of climacteric symptoms by geographical region S Palacios, VW Henderson, N Siseles, D Tan, P Villaseca Climacteric 13 (5), 419-428, 2010 | 507 | 2010 |
| Clinical subtypes of dementia of the Alzheimer type HC Chui, EL Teng, VW Henderson, AC Moy Neurology 35 (11), 1544-1544, 1985 | 441 | 1985 |
| Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health TJ De Villiers, A Pines, N Panay, M Gambacciani, DF Archer, RJ Baber, ... Climacteric 16 (3), 316-337, 2013 | 406 | 2013 |
| Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade? VW Henderson, GF Wooten Neurology 31 (2), 132-132, 1981 | 403 | 1981 |
| The epidemiology of estrogen replacement therapy and Alzheimer's disease VW Henderson Neurology 48 (5_suppl_7), 27S-35S, 1997 | 380 | 1997 |
| Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease LS Schneider, MR Farlow, VW Henderson, JM Pogoda Neurology 46 (6), 1580-1584, 1996 | 354 | 1996 |
| Prevention of diseases after menopause RA Lobo, SR Davis, TJ De Villiers, A Gompel, VW Henderson, HN Hodis, ... Climacteric 17 (5), 540-556, 2014 | 343 | 2014 |
| Supply and demand analysis of the current and future US neurology workforce TM Dall, MV Storm, R Chakrabarti, O Drogan, CM Keran, PD Donofrio, ... Neurology 81 (5), 470-478, 2013 | 339 | 2013 |
| Spatial disorientation in Alzheimer's disease VW Henderson, W Mack, BW Williams Archives of neurology 46 (4), 391-394, 1989 | 331 | 1989 |
| Hormone therapy and risk of Alzheimer disease: a critical time SM Resnick, VW Henderson Jama 288 (17), 2170-2172, 2002 | 321 | 2002 |
